Monografie
Determining the efficacy of antigen-armed antibody in B-cell lymphoma
- Sprache
-
Englisch
- Umfang
-
VIII, 111 S.
- Anmerkungen
-
Heidelberg, Univ., Diss., 2014 (Nicht für den Austausch)
- Identifier
-
1050942175
Thema
Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.04.2024, 08:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Panel sequencing of primary cutaneous B-cell lymphoma
Antibodies armed with microbial antigens in the treatment of B-cell lymphoma- characterization and development of a mouse model
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Antibody-mediated direct killing and senolytic capacity of two distinct anti-CD20 monoclonal antibodies in human diffuse large B-cell lymphoma cell lines
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Importance of NFAT and NF-κB signaling in Diffuselarge B-cell lymphoma
Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
Quantitative phosphoproteomics for studying B-cell receptor signaling in Burkitt’s lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Antibodies armed with microbial antigens in the treatment of B-cell lymphoma- characterization and development of a mouse model
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Antibody-mediated direct killing and senolytic capacity of two distinct anti-CD20 monoclonal antibodies in human diffuse large B-cell lymphoma cell lines
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Importance of NFAT and NF-κB signaling in Diffuselarge B-cell lymphoma
Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37
Quantitative phosphoproteomics for studying B-cell receptor signaling in Burkitt’s lymphoma
Panel sequencing of primary cutaneous B-cell lymphoma
Antibodies armed with microbial antigens in the treatment of B-cell lymphoma- characterization and development of a mouse model
Invasive Giant B-Cell Lymphoma Mimicking Fulminant Pulmonary Embolism
Targetable alterations in primary extranodal diffuse large B-cell lymphoma
Quantitative N-glycoproteome, phosphoproteome and ubiquitinome analyses for studying B-cell receptor signaling in B-cell lymphoma
Antibody-mediated direct killing and senolytic capacity of two distinct anti-CD20 monoclonal antibodies in human diffuse large B-cell lymphoma cell lines
Tumor progression in gastric marginal zone B-cell lymphoma of MALT type
COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma
Kruppel-like factor 4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classical Hodgkin lymphoma
Importance of NFAT and NF-κB signaling in Diffuselarge B-cell lymphoma
Fatty acid metabolism in aggressive B-cell lymphoma is inhibited by tetraspanin CD37